MILLIONS of women facing an elevated risk for breast cancer could slash their chances of getting the widely feared malignancy by taking a hormone-blocking pill used to treat the disease or prevent a recurrence, researchers say.
A compound known as an aromatase inhibitor cuts the breast cancer risk by 65 per cent for women prone to the disease for any reason, such as having risky genes, a relative who had the disease or being older than age 60, a long-awaited international study of more than 4500 women has concluded.
The results mark a highly anticipated advance towards the elusive goal of offering women the first safe way to protect themselves from a leading cancer killer. Women have long been able to take an older class of anti-estrogen drugs to reduce their risk, but few do because of possible side effects, including uterine cancer and life-threatening blood clots.
Many experts had hoped aromatase inhibitors would offer a safer, more acceptable alternative. The new study was the first time one had been tested.
A unanimous Court on June 12 made it easier for families to use the Americans with Disabilities...
US lawmakers on both sides of the aisle are raising concerns and seeking investigations in the...
